Compare LyondellBasell Industries NV (LYB) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Oscar Health Inc — how do they compare? LyondellBasell Industries NV trades at $60.03 (market cap $19.49B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: LyondellBasell Industries NV is the larger of the two by market cap, and LyondellBasell Industries NV pays a 4.57% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold LyondellBasell Industries NV for 87 Days and Oscar Health Inc for 15 Days on average.
| LYB | OSCR | |
|---|---|---|
Market Cap | $19.49B | $10.22B |
Volume | 6,033,396 | 4,123,394 |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $33.81 |
52-Week Low | $42.28 | $10.85 |
Typical Hold Time | 87 Days | 15 Days |
Enterprise Value | $31.08B | $6.57B |
Dividend Yield | 4.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LYB trades at $60.03, up 2.63% today, with a bearish technical signal despite recent earnings beats. The company reported strong Q2 2026 results with EPS of $4.30 beating expectations of $3.44, but faces fundamental challenges with negative net income margin of -1.13% and declining revenue from $50.5B in 2022 to $30.2B in 2025. Analyst consensus remains divided with 45% buy and 45% hold ratings, targeting $69.38 average price.
LYB shows operational resilience with improving cash flow projections for 2026, but faces significant headwinds from declining profitability and competitive pressures. The dividend yield remains attractive but sustainability concerns persist given the negative earnings trend. Near-term upside exists if operational improvements continue, though investors should monitor debt levels and chemical sector cyclicality.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
